Although our understanding of the molecular regulation of adult neovascularization has advanced tremendously, vascular-targeted therapies for tissue ischemia remain suboptimal. The master regulatory transcription factors of the hypoxia-inducible factor (HIF) family are attractive therapeutic targets because they coordinately up-regulate multiple genes controlling neovascularization. Here, we used an inducible model of epithelial HIF-1 activation, the TetON-HIF-1 mouse, to test the requirement for VEGF in HIF-1 mediated neovascularization. TetON-HIF-1, K14-Cre, and VEGF flox/flox alleles were combined to create TetON-HIF-1:VEGF Δ mice to activate HIF-1 and its target genes in adult basal keratinocytes in the absence of concomitant VEGF. HIF-1 induction failed to produce neovascularization in TetON-HIF-1:VEGF Δ mice despite robust up-regulation of multiple proangiogenic HIF targets, including PlGF, adrenomedullin, angiogenin, and PAI-1. In contrast, endothelial sprouting was preserved, enhanced, and more persistent, consistent with marked reduction in Dll4-Notch-1 signaling. Optical-resolution photoacoustic microscopy, which provides noninvasive, label-free, high resolution, and wide-field vascular imaging, revealed the absence of both capillary expansion and arteriovenous remodeling in serially imaged individual TetON-HIF-1:VEGF Δ mice. Impaired TetON-HIF-1: VEGF Δ neovascularization could be partially rescued by 12-O-tetradecanoylphorbol-13-acetate skin treatment. These data suggest that therapeutic angiogenesis for ischemic cardiovascular disease may require treatment with both HIF-1 and VEGF. vascular biology | conditional expression | photoacoustic tomography | capillary imaging N eovascularization is crucial for solid tumor growth and metastatic spread, for wound healing, and for tissue preservation and recovery after ischemia. Although tremendous progress has been made in understanding the molecular circuits regulating neovascularization in both benign and malignant disease, our knowledge remains incomplete. Solid tumors evade angiogenesis inhibitors, and efficacious therapeutic angiogenesis for tissue ischemia remains a tantalizing prospect.
The hypoxia-inducible factors-1 and -2 (HIF-1 and HIF-2) are αβ heterodimeric proteins that make crucial contributions to neovascularization in wound healing, and benign or malignant diseases (1, 2) . HIFs are master regulatory transcription factors with >100 known, and potentially hundreds more, target genes containing the core RCGTG enhancer sequence (3) (4) (5) (6) . A collection of HIF target genes coordinates neovascularization at several levels including endothelial cell proliferation, microvessel tone, vascular remodeling, and proangiogenic myeloid cell recruitment (7) .
Numerous reports suggested that HIF produced a more robust neovasculature, with more normal structure and function, compared with single angiogenic factor overexpression (2, (8) (9) (10) . However, the contribution of individual target genes encoding vascular functions to the collective HIF-1 neovascular phenotype is unknown. Here, we tested the hypothesis that VEGF was dispensable for HIF-mediated neovascularization. We used a unique conditional model of adult neovascularization in the skin, the TetON-HIF-1 transgenic mouse (11) that displays multistage neovascularization, and myeloid cell recruitment and retention in the absence of disease. TetON-HIF-1 mice were engineered for germ-line Cre-mediated VEGF deletion in the same basal keratinocytes targeted for conditional adult HIF-1α induction. VEGF deletion abrogated neovascularization despite coordinate upregulation of multiple angiogenic growth factors. Surprisingly, endothelial sprouting was activated after HIF-1 induction; however, these sprouts were nonproductive for neovessel development. Despite robust PlGF, adrenomedullin, and PAI-1 induction, HIF-1 activation in the absence of VEGF failed to affect vascular remodeling, and myeloid cell recruitment was markedly impaired. Thus, we provide evidence that VEGF is required for HIF-1-mediated adult neovascularization, but that certain elements of the angiogenic response proceed without this factor. To test the role of VEGF during epithelial HIF-1-induced neovascularization, we combined TetON-HIF-1 mice (11) with K14-Cre transgenic and VEGF floxed (VEGF f/f ) knock-in mice (12) (13) (14) (15) . The final genotype of these composite mice was K14-rtTA: TRE-HIF-1α P402A/P564A/N803A :K14-Cre:VEGF f/f . This genotype, designated as TetON-HIF-1:VEGF Δ , was n = 12 in the FVB/n strain. Doxycycline (DOX) treatment of 8-to 12-wk-old TetON-HIF-1:VEGF f/f mice induced a robust neovascularization that peaked and plateaued 14 d after initiation ( Fig. 1 A and B) . In contrast, neovascularization failed to occur in TetON-HIF-1: VEGF Δ composite mice ( Fig. 1 A and B) . Moreover, contrary to prior reports (16) , there was no reduction of microvascular density in TetON-HIF-1:VEGF Δ composite mice, at baseline before DOX induction compared with nontransgenic controls, likely due to differences in tissue fixation/epitope preservation techniques and endothelial marker antibody detection reagents. Induction of HIF-1α protein expression was detectable in both interfollicular epidermal and hair follicle outer root sheath basal keratinocytes in both TetON-HIF-1:VEGF Δ and TetON-HIF-1:VEGF f/f mice after 14 days of DOX induction (Fig. 1C) .
Temporal control of HIF-1 allowed us to deploy an emerging technology for noninvasive and label-free functional determination of microvascular dynamics, optical-resolution photo-acoustic microscopy (OR-PAM) (17, 18) . The resolving power and image segmentation capabilities of OR-PAM enabled multiparameter determination of vascular morphology including capillary volume as an indicator of angiogenesis, and arteriovenous (arteriolar/venular) volume, vessel length, diameter, and tortuosity as measures of vascular remodeling. Because OR-PAM uses hemoglobin for contrast (17) , both the imaging and quantitative segmentation analysis were based on perfused vessels, which, similar to ante mortem lectin perfusion (10) , is distinct from data derived from endothelial marker analysis of postmortem tissue sections. Serial OR-PAM monitoring of individual mice from days 0 to 60 of continuous DOX provision revealed that HIF-1 activation in TetON-HIF-1:VEGF f/f mice produced an eightfold increase in capillary volume and a 3.5-fold elevation of arteriovenous and overall vascular volume compared with DOX-induced TetON-HIF-1:VEGF Δ or day 0 TetON-HIF-1:VEGF f/f controls ( Fig. 2 A and Fig. S1B ). OR-PAM segmentation analysis suggested that capillary volume fell between days 14 and 30 in the TetON-HIF-1:VEGF f/f mice (Fig.  S1) . The difference between these data and the microvessel density analysis based on CD31 decoration of all vessels could be due to the lack of perfusion of CD31-positive vessels or that OR-PAM acquires wide field volumetric data and immunofluorescence analyzes microvascular area in 2D tissue sections. OR-PAM also demonstrated abrogation of HIF-1-mediated vasodilatation and tortuosity induction in the absence of epithelial VEGF (Fig. S1B) .
Loss of HIF-1-Induced VEGF Produces Sprouting Without Endothelial
Proliferation. An outstanding feature of the TetON-HIF-1 model is the ability to dissect discrete stages of neovascular network development and its maintenance due to temporal control of HIF-1 gain of function (11) . Here, we tested the necessity of VEGF for HIF-1 induction of the earliest stages of neovascularization, endothelial sprouting, and proliferation. DOX-treated NTG and day 0 TetON-HIF-1:VEGF f/f mice were used interchangeably in all studies, because they were phenotypically and functionally similar. (Fig. 3 , Right Middle). We further explored Notch-1 signaling by determining the expression kinetics and localization of the Notch intracellular domain (NICD), the product of the gamma secretase-mediated receptor cleavage and the active transcriptional Notch component (22) . The NICD was detectable in both the day 14 TetON-HIF-1:VEGF f/f endothelium and in basal keratinocytes (Fig. 3B, arrowheads) . In contrast, the NICD was detectable only in a few basal keratinocytes of TetON-HIF-1: VEGF Δ mice. The levels of Dll4 and the downstream Notch target Hey 1 mRNA were elevated 7-to 10-fold in TetON-HIF-1:VEGF f/f mice compared with 14-d DOX-treated NTG controls (Fig. 3C ). Dll4 and Hey-1 were induced at low, but statistically significant, levels in TetON-HIF-1:VEGF Δ mice compared with NTG controls (Fig. 3C) . Collectively, these data suggest that HIF-1 and its downstream targets (see below) are able to induce endothelial sprouting, yet these sprouts are nonproductive in forming neovessels in the absence of VEGF. The paucity of epidermal NICD in the TetON-HIF-1:VEGF Δ mice demonstrates that VEGF is re- By day 30, a significant increase in both CD45 and CD11b myeloid cells was achieved in TetON-HIF-1:VEGF Δ mice; however, these myeloid cells were insufficient to facilitate neovascularization in the absence of epithelial VEGF (Fig. 5 A-C and Fig. S4 ). Myeloid cell infiltration after chronic HIF-1 gain of function in DOX day 30 TetON-HIF-1:VEGF Δ mice was similar to our previous work with germ-line skin-targeted constitutive HIF-1 mutants in transgenic mice (37) . There, stromal myeloid cell trafficking was regulated by chemokines not VEGF.
12-O-Tetradecanoylphorbol-13-Acetate (TPA)-Induced Inflammation Produces Extensive Vascular Remodeling with Minimal Microvascular
Density Increase. Topical phorbol ester induces angiogenesis via enhanced VEGF secretion from the activated epithelium (38, 39) . Single-dose TPA treatment produces transient skin changes resolving after 3-4 d in wild type mice. Previously, we discovered that germ-line K14-HIF-1 P402A/P564G transgenic mice responded to single-dose TPA challenge with a marked and prolonged stromal and intraepithelial neutrophil infiltrate persisting for 3 wk (37). Neutrophil recruitment was secondary to HIF-1-enhanced NFκB signaling and NFκB chemokine target gene upregulation by transgenic keratinocytes. We capitalized on this strategy to determine whether the lack of HIF-1-mediated neovascularization in TetON-HIF-1:VEGF Δ vasculature could be rescued. TetON-HIF-1:VEGF Δ and TetON-HIF-1:VEGF f/f were DOX-induced for 14 d to prime the keratinocytes and stroma and emulate germ-line constitutive activation. One dose of topical TPA was followed by ear harvest 10 d later. As reported, TPA treatment produced a marked recruitment and retention of CD45 stromal myeloid cells in TetON-HIF-1:VEGF f/f mice (37), without affecting the frequency of CD11b macrophages ( Fig. S5 A and B) . Both TPA-treated DOX day 14 TetON-HIF-1: VEGF f/f and TetON-HIF-1:VEGF Δ mice ear epidermis was similarly punctuated by microabscesses filled with neutrophils (Fig. S6, Right) , an observation consistent with our previous findings (37). Moreover, TPA did not further augment VEGF expression or neovascularization in TetON-HIF-1:VEGF f/f mice ( Fig. 6 A and B) . In contrast, single-dose TPA in TetON-HIF-1: VEGF Δ mice produced a twofold increase in VEGF expression associated with a similar fold increase in neovessel area. TPA also produced a similar influx of neutrophils in TetON-HIF-1: VEGF Δ mice (Fig. S5A, Left and B, Upper) . Partial rescue of HIF-1-mediated neovascularization in TetON-HIF-1:VEGF Δ mice was associated with expansion of an epidermal population of unrecombined VEGF f/f alleles and abscess-derived neutrophils (Fig. S5B) . However, VEGF expression was undetectable in the majority of stromal neutrophils not associated with intraepidermal abcesses. TPA treatment also produced a statistically significant increase in capillary and total vessel volume, and a trend towards an increase in vessel tortuosity, as determined by OR-PAM (Fig. S7 A and B) .
Discussion
In this study, we used a conditional mouse model to discover that VEGF, among a repertoire of induced angiogenic target genes, was necessary for HIF-1-mediated neovascularization. Targeting Tet-regulated HIF-1α to the skin had several advantages. We were able to use unfurred ear skin, enabling visual assessment of neovascular progression. The ear possessed a stereotypic histological architecture with a sharply delineated boundary between the transgene expressing basal keratinocytes and the underlying neovessel and inflammatory cell containing stroma. These features allowed us to determine alterations in tissue molecular signaling and immunofluorescent localization of induced signaling events covering the entire spectrum of neovascularization, from initial endothelial cell activation to development and maintenance of a complete neovascular network. This combination of tissue organization for molecular expression localization and immediate tissue sampling of an activated vasculature was distinct from disease models that required a lag phase to allow tumors to grow or ischemic neovascularization to become established. Other studies used adenoviral expression systems to create controlled timedependent ear neovascularization (40) . This approach had two challenges. First, there was an abrupt and massive overexpression of angiogenic factors followed by rapid decline. Second, viral particles were deposited in the stroma, an approach that did not model angiogenic signaling from an activated epithelium that, because it is initiated in the premalignant dysplasia, is an important component of multistage epithelial carcinogenesis (41) .
As expected, we detected DOX-induced up-regulation of multiple angiogenic target genes that could have compensated for VEGF deficiency in TetON-HIF-1:VEGF Δ mice. A lead example was the indirect HIF target PlGF. PlGF binds and activates VEGFR1 and induces phosphorylation of a repertoire of target In contrast, Dll4 and Hey-1 were induced at low, albeit statistically significant levels in VEGF Δ mice. Data are mean ± SD. Statistical analysis was the unpaired Student t test comparing each VEGF Δ or VEGF f/f DOX treatment day to comparably treated NTG controls: *P < 0.05, **P < 0.01 and ***P < 0.001. proteins distinct from VEGFR2 in endothelial cells (42, 43) . PlGF has been shown to amplify or inhibit VEGF signaling through multiple mechanisms (44, 45) . PlGF was angiogenic when targeted for overexpression in basal keratinocytes (23) , or after local adenoviral injection in the skin or aortic adventitia (24, 25) . PlGF gene deletion or antibodies targeting PlGF inhibited tumor growth via multiple mechanisms, including inhibition of angiogenesis, myeloid cell, and hematopoietic precursor mobilization (24, 35, 36) . In models of tissue ischemia, PlGF was required for vascular dilatation and collateralization (24, 46) . Thus, we were surprised that despite robust PlGF induction, angiogenesis, vascular dilatation, arteriovenous remodeling, and myeloid cell recruitment were unaffected by HIF-1 induction in the absence of VEGF. As such, our work is consistent with the VEGF signaling amplification function of PlGF, but is in contrast to "direct" angiogenesis induction of prior skin and adenoviral studies. The VEGF dominance in our model is also in line with recent studies questioning the contribution of PlGF to angiogenesis (47, 48) .
In addition to PlGF, other angiogenic targets and vascular remodeling molecules were up-regulated in TetON-HIF-1: VEGF Δ mice. The HIF target adrenomedullin was shown to promote physiological and pathological angiogenesis in vitro and in animal models (49) (50) (51) . ADM signals angiogenesis by binding calcitonin-receptor-like receptor, which is widely expressed on normal and hypoxic endothelial cells (49, 52) . Angiogenin was another molecule previously demonstrated to be angiogenic, yet without consequence in TetON-HIF-1:VEGF Δ mice (28, 29) . In addition to these direct proangiogenic HIF targets, molecules contributing accessory functions such as matrix degradation and its modulation, MMP9, MMP3, and PAI-1, and vascular dilatation, iNOS, were also up-regulated in TetON-HIF-1:VEGF Δ mice. Thus, many of the molecules in the angiogenic "toolbox" were elevated by HIF-1, yet all required coordinate VEGF up-regulation to affect neovascularization and its modulation. Our data provide additional insight into studies wherein deletion of the VEGF HIF hypoxia response element (HRE) in ES cells or targeted germ-line VEGF gene deletion in keratinocytes diminished tumor growth (53) or delayed normal wound healing (16), respectively. However, in each of these studies, variable levels of neovascularization were present, likely from compensatory angiogenic factors. Our use of topical TPA challenge with its attendant prolonged stromal inflammation and neovascularization rescue emulated disease-associated angiogenic compensation. We were surprised that the VEGF increment induced by TPA in TetON-HIF-1:VEGF Δ mice was not due to the numerous neutrophils infiltrating throughout the stroma. Rather, the VEGF increment was localized to the epidermis, likely due to expansion of a small population of preexisting basal keratinocytes with unrecombined VEGF f/f alleles and to focal neutrophil accumulations beneath intraepidermal abscesses. These data did not rule out a neovessel activation function for the stromal neutrophils, which have been shown in previous studies to be sources of compensatory angiogenic factors such as FGF-2 in tumors during VEGF signaling blockade (54) . As such, our conditional model enabled precise genetic dissection of "intrinsic" HIF-1 functions while enabling titration of pathophysiological processes to test for complementation of baseline neovascularization deficiencies.
Finally, ear skin allowed us to continue to use an emerging technique for determination of neovascular architecture and microvessel function photoacoustic microscopy (PAM) (17) . PAM and the derivative used in our study, OR-PAM, use red blood cell (RBC) hemoglobin for endogenous contrast. Diffraction-limited optical focusing and exquisite (100%) sensitivity to optical absorption enables single RBC resolution and capillary resolution in vivo (18) . Additionally, the wide field of view of OR-PAM enabled us to determine the necessity of VEGF for both angiogenesis and arteriovenous remodeling in the context of HIF-1 induction. These features plus simultaneous determination of multiple parameters of neovascular function and tissue metabolism will be a boon for future studies in models of neovascular disease (17) .
In conclusion, we demonstrate that despite induction of multiple angiogenic target genes, VEGF is necessary for HIF-1 mediated neovascularization. The VEGF requirement can be substantially, although not entirely, rescued by chemokine-activated keratinocytes and neutrophils accumulating adjacent to abscesses. Recent studies have demonstrated provocative linkage between age, cardiovascular disease, and insufficiency of HIF-1 expression in both ischemic tissues and infiltrating myeloid cells (55, 56) . Because aging can also impair induction of VEGF expression (57, 58) , our work suggests that therapeutic angiogenesis may require combinatorial restoration or administration of both HIF-1 and VEGF to achieve optimal tissue neovascularization.
Materials and Methods
Mouse Development, Target Expression Analysis, Photoacoustic Microscopy, and Inflammation Challenge. Detailed description of the mouse intercrosses to generate target and control genotypes, tissue molecular and expression analysis, photoacoustic microscopy, and inflammation challenge experiments are available in SI Materials and Methods. The Animal Studies Committee of Washington University in St. Louis approved all animal care and experimental procedures. 
